Next Generation Sternal Healing ThoraGraft (tm)
Proprietary Design, Sternal Bone Graft for Better Patient Outcomes
Next Generation Sternal Healing ThoraGraft (tm)
Proprietary Design, Sternal Bone Graft for Better Patient Outcomes
A simple solution to a complex issue
ThoraGraft
Significantly diminishes pain, bleeding and infection resulting in less hospital stays
management team
Frederick "Rick Thabet
Frederick "Rick Thabet
Frederick "Rick Thabet
Co-Founder & Chief Executive Officer
Ravi Kanagala
Frederick "Rick Thabet
Frederick "Rick Thabet
Co-Founder & Chief Medical Officer
John C. May
Frederick "Rick Thabet
Durand "Randy" Achée
Corporate Development
Durand "Randy" Achée
Durand "Randy" Achée
Durand "Randy" Achée
Board Advisor: Marketing & Strategic Development
Keri George
Durand "Randy" Achée
Keri George
Director of Clinical Affairs
Mehdi Garti
Durand "Randy" Achée
Keri George
Director of Engineering:
Product Development
our strategic Partner: AlloSource®
Working Together for Better Patient Outcomes
AlloSource® is a nonprofit organization founded in 1994. Inspired by the gift of donation from their communities, AlloSource® responsibly provides innovative cellular and tissue allografts to advance patient healing.
They offer more than 200 types of precision bone, skin, soft-tissue and custom-machined allografts for use in an array of life-saving and life-enhancing medical procedures.
AlloSource ® is the world’s largest processor of cellular bone allografts and deliver unparalleled expertise and customer service to a growing network of surgeons, partners and the country’s most reputable Organ Procurement Organizations.
